Skip to content

Stroke education by emphasizing self-confidence to reduce risk factors and improve clinical outcomes for mild to moderate stroke patients

Exploring the self-efficacy and self-care based stroke care model for risk factor modification in mild to moderate stroke patients: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11495822
Enrollment
120
Registered
2023-01-05
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduction of stroke risk factors through patient education based on self-care and self-efficacy Circulatory System

Interventions

The researchers enrol mild to moderate ischemic stroke patients during hospitalization in either the emergency department or the stroke unit at Cipto Mangunkusumo National Hospital. After informed con

Sponsors

University of Indonesia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with mild to moderate ischemic stroke based on a clinical definition of focal neurologic deficits consistent with the vascular territory of the brain 2. Aged over 18 years at onset of event 3. Lived around Jakarta during the research process 4. Discharge to home 5. Speaking Indonesian

Exclusion criteria

Exclusion criteria: 1. Patients unable to give informed consent 2. Discharged to a long-term nursing home 3. Pre-stroke dementia history 4. Patients with end-stage cancer or other medical conditions resulting in mortality of less than 1 year

Design outcomes

Primary

MeasureTime frame
1. Self-care and self-efficacy level is measured using the Hypertension Self-Care Instrument at baseline, 1 month, and 3 months after discharge 2. Stroke risk is measured using the Feigin Stroke Risk Score at baseline, 1 month, and 3 months after discharge

Secondary

MeasureTime frame
1. Blood viscosity measured using a micropapillary device at baseline, 1 month, and 3 months after discharge 2. Functional outcome measured using the modified Rankin Scale (mRS) score and Barthel index at baseline, 1 month, and 3 months after discharge 3. Element of risk factor for stroke measured using the Feigin Stroke Risk Score at baseline, 1 month, and 3 months after discharge

Countries

Indonesia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026